Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Portfolio News

Portfolio News

Curate Biosciences launches its first product to transform cell therapy manufacturing costs and performance

Portfolio News

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation

Portfolio News

Curate Biosciences Announces David Backer as Chief Executive Officer

Portfolio News

Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology

Portfolio News

Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million

Portfolio News

Moxe Health Raises $30M Series B to Further Advance Interoperability

Portfolio News

Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics

Portfolio News

Apella Announces $21 Million Series A Funding to Digitize the Operating Room

Portfolio News

Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical

Portfolio News

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering

Portfolio News

This AI Startup Raised $43 Million To Save Lives (And Money) By Treating Heart Disease Earlier

Portfolio News

Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease

Portfolio News

GPB Scientific Announces Additional Growth Financing to Support Commercialization of Curate™ Cell Processing System for Next-Generation Cell & Gene Therapies

Portfolio News

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Portfolio News

SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases

Portfolio News

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

Portfolio News

Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular

Portfolio News

CVRx® Raises $50 Million in New Equity Financing

Portfolio News

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

Portfolio News

Two medical device makers in Wayne get big boosts

Portfolio News

Wayne medical device developer and its spin-off reel in $62 million

Portfolio News

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™

Portfolio News

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

Portfolio News

Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

40

Level I Clinical Trials

32

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
MedTech Strategist: Vensana Capital Closes Its Third Medtech Fund for $425 Million
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions